Grassley: Lawmakers Wrong To Ax DTC Price Measure, But HHS Can Still Require It

By Donna Haseley / September 14, 2018 at 6:14 PM
Sen. Chuck Grassley (R-IA) chided HHS appropriations conferees for axing his bipartisan amendment giving FDA money to require drug prices be disclosed on direct-to-consumer ads, but he added HHS still has the authority to mandate the disclosure. “The good news is that the Department of Health and Human Services has the authority to make this happen. Secretary Azar has spoken clearly about his support for this policy and transparency on behalf of consumers concerning prescription drugs. The Administration has also...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.